Related Experiment Video
Updated: May 31, 2026

06:32
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
Published on: May 2, 2025
442
Key markers and detection methods for evaluating platelet dysfunction in mechanical circulatory support devices
Zhenling Wei1, Zhuo Li2, Wangwang Su2
1Artificial Organ Technology Laboratory, School of Mechanical and Electrical Engineering, Soochow University, Suzhou, 215006, China. 20225229107@stu.suda.edu.cn.
Summary
Mechanical circulatory support devices (MCSDs) can cause platelet dysfunction due to non-physiological shear stress (NPSS), increasing risks of thrombosis and bleeding. Research focuses on markers like phosphatidylserine (PS) and thrombin to improve MCSD safety.
Area of Science:
- Biomaterials Science
- Hematology
- Medical Devices
Background:
- Mechanical circulatory support devices (MCSDs) are vital for end-stage heart failure but pose hemocompatibility challenges.
- Non-physiological shear stress (NPSS) from MCSDs induces platelet dysfunction, leading to thrombotic and bleeding risks.
Purpose of the Study:
- To review the hemostatic process, NPSS effects on platelets, and markers/assays for platelet dysfunction in MCSD therapy.
- To identify key markers and methods for assessing and potentially mitigating NPSS-induced platelet dysfunction.
Main Methods:
- Literature review synthesizing knowledge on hemostasis, NPSS, platelet markers, and detection assays.
- Discussion of techniques including FACS, ELISA, PAS assay, SEM, and fluorescence microscopy.
- Focus on specific markers such as P-selectin, platelet-derived microparticles (PDMPs), phosphatidylserine (PS), and thrombin.
Main Results:
- NPSS triggers platelet activation and receptor shedding, resulting in both thrombosis and bleeding.
- Phosphatidylserine (PS) and thrombin show unique responses to NPSS, indicating their potential as targeted markers.
- Morphological and aggregation assessments offer visualized insights into NPSS-mediated platelet dysfunction.
Conclusions:
- Combining diverse markers and assays is crucial for understanding and mitigating NPSS-induced complications in MCSD therapy.
- Future research should validate NPSS-specific biomarkers and standardize detection methods.
- Elucidating interactions with hemolysis and coagulopathy is essential for improving MCSD safety and efficacy.

